Number of employees
15-29
As an agent for Kirin, Gemini is continuously searching for novel technologies and pharmaceutical products which represent licensing and/or partnering opportunities attractive to Kirin’s business platforms. Gemini is interested in products and technologies that have been developed in both academic and industrial sectors. For potential in-licensing to Kirin, Gemini is looking for product candidates at any stage of development in the following core disease areas: Oncology, renal diseases, immune disorders and allergy. Gemini also seeks partners who have novel technologies that can facilitate Kirin’s R&D efforts in the following fields: